Overall survival over time of donor arm versus no-donor arm. Estimate of overall survival probability for donor arm versus no-donor arm over 3 years. Improvement in overall survival was statistically significant for MDS patients who underwent reduced-intensity HCT when compared with MDS patients without a donor. Adapted from Nakamura R et al. J Clin Oncol. 2021;39(30):3328-3339, under a Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/.